Skip to content

Clinical trials

Phase 1 Brain Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20202
20212
20224
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed3
Recruiting3
Not yet recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Genor Biopharma Co., Ltd.1
Guangdong 999 Brain Hospital1
Guangzhou JOYO Pharma Co., Ltd1
Hubei Cancer Hospital1
Peking Union Medical College Hospital1
Pfizer1
Second Affiliated Hospital of Guangzhou Medical University1
Shanghai Pudong Hospital1
Shanghai Yunying Medical Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms14
Breast Neoplasms3
Lung Neoplasms3
Glioma2
Melanoma2
Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Central Nervous System Neoplasms1
Colonic Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.